We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$125B
AUM Growth
+$7.74B
(+6.6%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
32.47%
Holding
4,267
New
79
Increased
1,134
Reduced
2,614
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$80.1M |
| 2 |
Chevron
CVX
|
+$75.4M |
| 3 |
Robinhood
HOOD
|
+$52.2M |
| 4 |
Nutanix
NTNX
|
+$32.2M |
| 5 |
Datadog
DDOG
|
+$29.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$166M |
| 2 |
Apple
AAPL
|
+$150M |
| 3 |
NVIDIA
NVDA
|
+$148M |
| 4 |
HES
Hess
HES
|
+$72.3M |
| 5 |
ANSS
Ansys
ANSS
|
+$59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.89% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Communication Services | 9.45% |
| 5 | Healthcare | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBNX
2226
Beta Bionics
BBNX
$715M
| $936K | ﹤0.01% |
47,117
+28,678
| +156% | +$504K |
|
|
AMRZ
2227
Amrize Ltd
AMRZ
$25.8B
| $935K | ﹤0.01% |
+19,276
| New | +$983K |
|
2228
Usana Health Sciences
USNA
$286M
| $935K | ﹤0.01% |
33,951
-85
| -0.2% | -$2.62K |
|
|
MLNK
2229
DELISTED
MeridianLink
MLNK
| $935K | ﹤0.01% |
46,923
-1,659
| -3% | -$30.5K |
|
2230
Sinclair Inc
SBGI
$1.03B
| $933K | ﹤0.01% |
61,813
-420
| -0.7% | -$6.03K |
|
2231
Teekay
TK
$985M
| $933K | ﹤0.01% |
114,015
-12,319
| -10% | -$98K |
|
|
UPB
2232
Upstream Bio Inc
UPB
$395M
| $929K | ﹤0.01% |
49,406
+1,340
| +3% | +$20.8K |
|
2233
Cooper-Standard Automotive
CPS
$558M
| $929K | ﹤0.01% |
25,158
-986
| -4% | -$30.1K |
|
2234
LSI Industries
LYTS
$924M
| $927K | ﹤0.01% |
39,282
-1,222
| -3% | -$24.8K |
|
|
AIOT
2235
PowerFleet Inc
AIOT
$592M
| $927K | ﹤0.01% |
176,883
-7,815
| -4% | -$36.1K |
|
2236
iRadimed
IRMD
$1.18B
| $922K | ﹤0.01% |
12,961
-6,580
| -34% | -$438K |
|
|
GOOD
2237
Gladstone Commercial Corp
GOOD
$627M
| $921K | ﹤0.01% |
74,727
-4,359
| -6% | -$58.1K |
|
2238
Stagwell
STGW
$2.24B
| $920K | ﹤0.01% |
163,372
-18,935
| -10% | -$100K |
|
|
HTBK
2239
DELISTED
Heritage Commerce
HTBK
| $918K | ﹤0.01% |
92,427
-17,015
| -16% | -$171K |
|
2240
Hippo Holdings
HIPO
$861M
| $915K | ﹤0.01% |
25,289
-522
| -2% | -$16.2K |
|
|
BORR
2241
Borr Drilling
BORR
$1.19B
| $914K | ﹤0.01% |
339,675
-29,102
| -8% | -$72.4K |
|
2242
Capital City Bank Group
CCBG
$890M
| $913K | ﹤0.01% |
21,850
-144
| -0.7% | -$5.99K |
|
2243
Gray Television
GTN
$552M
| $912K | ﹤0.01% |
157,737
+12,287
| +8% | +$66.7K |
|
2244
Excelerate Energy
EE
$1.11B
| $910K | ﹤0.01% |
36,121
-3,023
| -8% | -$75.5K |
|
2245
Tango Therapeutics
TNGX
$4.41B
| $906K | ﹤0.01% |
107,839
-4,434
| -4% | -$30K |
|
2246
Oil-Dri
ODC
$1.34B
| $904K | ﹤0.01% |
14,805
-413
| -3% | -$25.1K |
|
2247
Amerant Bancorp
AMTB
$1.13B
| $900K | ﹤0.01% |
46,704
-774
| -2% | -$15.6K |
|
2248
BlueLinx
BXC
$706M
| $900K | ﹤0.01% |
12,315
-487
| -4% | -$38.4K |
|
2249
AnaptysBio
ANAB
$1.68B
| $895K | ﹤0.01% |
29,244
-1,461
| -5% | -$33.5K |
|
|
PSIX
2250
Power Solutions International
PSIX
$942M
| $892K | ﹤0.01% |
9,085
-350
| -4% | -$31K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2025 Portfolio in Review
As of Q3 2025, RhumbLine Advisers held 4,267 positions worth $125B, up 6.6% from $117B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.2%. RhumbLine Advisers opened 79 new positions and exited 100, leaving the 4,267-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q3 2025 buy was The Marzetti Company: 64,390 shares worth $11.1M.
- RhumbLine Advisers added most to Applovin in Q3 2025, an estimated $80.1M increase.
- RhumbLine Advisers's biggest Q3 2025 reduction was Microsoft, cutting an estimated $166M.
- RhumbLine Advisers fully exited Hess in Q3 2025, selling an estimated $72.3M.
- RhumbLine Advisers's ten largest holdings make up 32% of its $125B portfolio in Q3 2025.
- RhumbLine Advisers opened 79 new positions and closed 100 in Q3 2025.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $125B.
Based on RhumbLine Advisers's 13F filing for Q3 2025, filed 6 Nov 2025.